Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.
Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, Stephenson I. Clark TW, et al. Among authors: hoschler k. N Engl J Med. 2009 Dec 17;361(25):2424-35. doi: 10.1056/NEJMoa0907650. Epub 2009 Sep 10. N Engl J Med. 2009. PMID: 19745215 Free article. Clinical Trial.
High attack rate in a large care home outbreak of SARS-CoV-2 BA.2.86, East of England, August 2023.
Reeve L, Tessier E, Trindall A, Abdul Aziz NIB, Andrews N, Futschik M, Rayner J, Didier'Serre A, Hams R, Groves N, Gallagher E, Graham R, Kele B, Hoschler K, Fowler T, Blandford E, Mahgoub H, Hoffmann J, Ramsay M, Dabrera G, Chand M, Zambon M, Sharp A, Heinsbroek E, Lopez Bernal J. Reeve L, et al. Among authors: hoschler k. Euro Surveill. 2023 Sep;28(39):2300489. doi: 10.2807/1560-7917.ES.2023.28.39.2300489. Euro Surveill. 2023. PMID: 37768561 Free PMC article.
Paediatric acute hepatitis of unknown aetiology: a national investigation and adenoviraemia case-control study in the UK.
Mandal S, Simmons R, Ireland G, Charlett A, Desai M, Coughlan L, Powell A, Leeman D, Williams C, Neill C, O'Leary MC, Sawyer C, Rowley F, Harris C, Houlihan C, Gordon C, Rampling T, Callaby H, Hoschler K, Cogdale J, Renz E, Sebastianpilli P, Thompson C, Talts T, Celma C, Davies EA, Ahmad S, Machin N, Gifford L, Moore C, Dickson EM, Divala TH, Henderson D, Li K, Broadbent P, Ushiro-Lumb I, Humphreys C, Grammatikopoulos T, Hartley J, Kelgeri C, Rajwal S, Okike I, Kelly DA, Guiver M, Borrow R, Bindra R, Demirjian A, Brown KE, Ladhani SN, Ramsay ME, Bradley DT, Gjini A, Roy K, Chand M, Zambon M, Watson CH. Mandal S, et al. Among authors: hoschler k. Lancet Child Adolesc Health. 2023 Nov;7(11):786-796. doi: 10.1016/S2352-4642(23)00215-8. Epub 2023 Sep 26. Lancet Child Adolesc Health. 2023. PMID: 37774733 Free article.
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.
Stephenson I, Nicholson KG, Hoschler K, Zambon MC, Hancock K, DeVos J, Katz JM, Praus M, Banzhoff A. Stephenson I, et al. Among authors: hoschler k. N Engl J Med. 2008 Oct 9;359(15):1631-3. doi: 10.1056/NEJMc0805274. N Engl J Med. 2008. PMID: 18843132 No abstract available.
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.
Galli G, Hancock K, Hoschler K, DeVos J, Praus M, Bardelli M, Malzone C, Castellino F, Gentile C, McNally T, Del Giudice G, Banzhoff A, Brauer V, Montomoli E, Zambon M, Katz J, Nicholson K, Stephenson I. Galli G, et al. Among authors: hoschler k. Proc Natl Acad Sci U S A. 2009 May 12;106(19):7962-7. doi: 10.1073/pnas.0903181106. Epub 2009 Apr 27. Proc Natl Acad Sci U S A. 2009. PMID: 19416838 Free PMC article. Clinical Trial.
A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies.
Temperton NJ, Hoschler K, Major D, Nicolson C, Manvell R, Hien VM, Ha do Q, de Jong M, Zambon M, Takeuchi Y, Weiss RA. Temperton NJ, et al. Among authors: hoschler k. Influenza Other Respir Viruses. 2007 May;1(3):105-12. doi: 10.1111/j.1750-2659.2007.00016.x. Influenza Other Respir Viruses. 2007. PMID: 19453415 Free PMC article.
Reproducibility of serologic assays for influenza virus A (H5N1).
Stephenson I, Heath A, Major D, Newman RW, Hoschler K, Junzi W, Katz JM, Weir JP, Zambon MC, Wood JM. Stephenson I, et al. Among authors: hoschler k. Emerg Infect Dis. 2009 Aug;15(8):1252-9. doi: 10.3201/eid1508.081754. Emerg Infect Dis. 2009. PMID: 19751587 Free PMC article.
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial.
Nicholson KG, Abrams KR, Batham S, Clark TW, Hoschler K, Lim WS, Medina MJ, Nguyen-Van-Tam JS, Read RC, Warren FC, Zambon M. Nicholson KG, et al. Among authors: hoschler k. Lancet Infect Dis. 2011 Feb;11(2):91-101. doi: 10.1016/S1473-3099(10)70296-6. Epub 2010 Dec 16. Lancet Infect Dis. 2011. PMID: 21168369 Clinical Trial.
Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.
Puleston RL, Bugg G, Hoschler K, Konje J, Thornton J, Stephenson I, Myles P, Enstone J, Augustine G, Davis Y, Zambon M, Nicholson KG, Nguyen-Van-Tam JS. Puleston RL, et al. Among authors: hoschler k. Health Technol Assess. 2010 Dec;14(55):1-82. doi: 10.3310/hta14550-01. Health Technol Assess. 2010. PMID: 21208547 Free article.
A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart.
Nicholson KG, Abrams KR, Batham S, Clark TW, Hoschler K, Lim WS, Medina M, Nguyen-Van-Tam JS, Read RC, Warren FC, Zambon M. Nicholson KG, et al. Among authors: hoschler k. Health Technol Assess. 2010 Dec;14(55):193-334. doi: 10.3310/hta14550-04. Health Technol Assess. 2010. PMID: 21208550 Free article. Clinical Trial.
122 results